Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Ovarian”

4,029 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,029 results

Not applicableActive Not RecruitingNCT05708703
What this trial is testing

Assessing the Time Demands of Cancer

Who this might be right for
Metastatic Breast CancerOvarian Cancer
Masonic Cancer Center, University of Minnesota 78
Not applicableStudy completedNCT00001938
What this trial is testing

A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)

Who this might be right for
Ovarian Neoplasm
National Cancer Institute (NCI) 26
Large-scale testing (Phase 3)Ended earlyNCT02470585
What this trial is testing

Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerOvarian Neoplasm
AbbVie 1,140
Not applicableUnknownNCT05640024
What this trial is testing

Prospective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR Inhibitors

Who this might be right for
Ovarian Cancer
Yonsei University 54
Post-approval studies (Phase 4)Study completedNCT00727961
What this trial is testing

Evaluate Efficacy and Tolerance of Caelyx in Patients With Epithelial Ovarian Cancer. (Study P04072)(COMPLETED)

Who this might be right for
Ovarian Neoplasms
Merck Sharp & Dohme LLC 58
Not applicableLooking for participantsNCT05761561
What this trial is testing

Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer

Who this might be right for
Ovarian Cancer
Yale University 200
Testing effectiveness (Phase 2)Study completedNCT00231855
What this trial is testing

Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers

Who this might be right for
Ovarian NeoplasmsUterine Neoplasms
Montefiore Medical Center 31
Very early researchStudy completedNCT03832985
What this trial is testing

Pediatric Reporting of Adult-Onset Genomic Results

Who this might be right for
Hereditary Breast and Ovarian Cancer SyndromeLynch SyndromeFamilial Hypercholesterolemia
Geisinger Clinic 162
Testing effectiveness (Phase 2)UnknownNCT00021385
What this trial is testing

Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer

Who this might be right for
Ovarian Cancer
Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)Not Yet RecruitingNCT06751485
What this trial is testing

JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer

Who this might be right for
Ovarian CancerPrimary PeritonealFallopian Tube Cancers
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 430
Early research (Phase 1)Study completedNCT00666991
What this trial is testing

Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers

Who this might be right for
Peritoneal Neoplasms
CritiTech, Inc. 22
Early research (Phase 1)Ended earlyNCT03162562
What this trial is testing

The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer

Who this might be right for
Cancer of OvaryNeoplasms, OvarianOvarian Cancer Stage IV+3 more
CanariaBio Inc. 10
Large-scale testing (Phase 3)UnknownNCT01654146
What this trial is testing

ICON8: Weekly Chemotherapy in Ovarian Cancer

Who this might be right for
Ovarian Cancer
Medical Research Council 1,485
Not applicableStudy completedNCT00342446
What this trial is testing

A Follow-up Study of Women Evaluated and Treated for Infertility

Who this might be right for
Ovarian CancerBreast CancerEndometrial Cancer+2 more
National Cancer Institute (NCI) 12,193
Testing effectiveness (Phase 2)WithdrawnNCT06545617
What this trial is testing

A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer

Who this might be right for
Platinum-resistant Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Bio-Thera Solutions
Not applicableStudy completedNCT00538603
What this trial is testing

Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)

Who this might be right for
Epithelial Ovarian Cancer
King Faisal Specialist Hospital & Research Center 8
Large-scale testing (Phase 3)UnknownNCT00954174
What this trial is testing

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

Who this might be right for
Mixed Mesodermal (Mullerian) TumorOvarian CarcinosarcomaRecurrent Fallopian Tube Carcinoma+39 more
GOG Foundation 637
Not applicableLooking for participantsNCT06689605
What this trial is testing

Ultrasound-guided Tru-cut Biopsy in Patients with Suspected Ovarian Cancer: Adequacy, Accuracy, Safety and Patient Assessment.

Who this might be right for
Ovarian Cancer
University Hospital Hradec Kralove 30
Early research (Phase 1)Looking for participantsNCT07524322
What this trial is testing

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

Who this might be right for
Breast CancerOvarian CancerEndometrial Cancer+6 more
Regor Pharmaceuticals Inc. 63
Testing effectiveness (Phase 2)Study completedNCT01196559
What this trial is testing

Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
The Catholic University of Korea 44
Load More Results